Risk stratification of patients diagnosed with gastrointestinal stromal tumor
Top Cited Papers
- 5 September 2008
- journal article
- research article
- Published by Elsevier
- Vol. 39 (10) , 1411-1419
- https://doi.org/10.1016/j.humpath.2008.06.025
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KITJournal of Clinical Oncology, 2008
- Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based studyBMC Cancer, 2007
- An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumorsInternational Journal of Clinical Oncology, 2007
- Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal TumorAnnals of Surgical Oncology, 2007
- Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate eraCancer, 2005
- Prognostic factors after surgery of primary resectable gastrointestinal stromal tumoursEuropean Journal of Surgical Oncology, 2004
- Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal TumorsClinical Cancer Research, 2004
- Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patientsGastric Cancer, 2003
- Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumoursBritish Journal of Surgery, 2003
- Prognostic Value ofKITMutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal TumorsJournal of Clinical Oncology, 2002